REQUEST A DEMO
Total
USD $0.00
Search more companies

Razak Laboratories Company Public Joint Stock (Iran)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Razak Laboratories Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Razak Pharmaceutical Laboratories is an Iranian shareholding company, established in 1964 as a subsidiary of Pfizer International Company. It produces 70 pharmaceutical products under generic or brand names for human and veterinary treatment. Part of Razak’s production is exported to Afghanistan, Turkmenistan, Armenia and Azerbaijan. Razak has even incorporated a subsidiary in Azerbaijan under the name Azerpharm. The company also holds the majority stake in the veterinary drug manufacturer Damloran.

Headquarters
Km 10,Lashgari Expy, In Front Of Pars Minoo Company, Po Box 13185-1671
Tehran; Tehran; Postal Code: 1389736615

Contact Details: Purchase the Razak Laboratories Company Public Joint Stock report to view the information.

Website: http://www.razakpharma.com

Basic Information
Total Employees:
Purchase the Razak Laboratories Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Razak Laboratories Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Razak Laboratories Company Public Joint Stock report to view the information.
Incorporation Date:
1964
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
3%
Purchase this report to view the information.
2%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Shahid Ghazi Pharmaceutical Company Public Joint Stock
14.5%
Company Performance
Financial values in the chart are available after Razak Laboratories Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
-19.55%
Total operating revenue
-13.37%
Operating profit (EBIT)
-66.85%
EBITDA
-66.12%
Net Profit (Loss) for the Period
-89.37%
Total assets
16.84%
Total equity
-51.42%
Operating Profit Margin (ROS)
-24.07%
Net Profit Margin
-20.28%
Return on Equity (ROE)
-32.59%
Debt to Equity Ratio
101.07%
Quick Ratio
-0.23%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?